Sfoglia per Autore
New onset left atrial dilatation in the general population: A quarter-century follow-up
2025 Cuspidi, C; Facchetti, R; Quarti-Trevano, F; Dell'Oro, R; Faggiano, A; Mancia, G; Grassi, G
Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials
2025 Manolis, A; Karakasis, P; Patoulias, D; Doumas, M; Kallistratos, M; Thomopoulos, C; Koutsaki, M; Grassi, G; Mancia, G
When should antihypertensive drug treatment be started? Discrepancies between the 2023 European Society of Hypertension and the 2024 European Society of Cardiology guidelines
2025 Mancia, G; Grassi, G; Kjeldsen, S
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity
2025 Quarti-Trevano, F; Seravalle, G; Facchetti, R; Tsioufis, K; Dimitriadis, K; Manta, E; Mancia, G; Grassi, G
The Autonomic Nervous System and Inflammation in Chronic Kidney Disease
2025 Zoccali, C; Mallamaci, F; Kanbay, M; Tuttle, K; Kotanko, P; De Caterina, R; Grassi, G; Mancia, G
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY
2025 Massabò, D; Quarti-Trevano, F; Seravalle, G; Facchetti, R; Dell'Oro, R; Tsioufis, K; Dimitriadis, K; Manta, E; Mancia, G; Grassi, G
Increased arterial stiffness and left ventricular remodelling as markers of masked hypertension: findings from the PAMELA population
2025 Cuspidi, C; Facchetti, R; Gherbesi, E; Quarti-Trevano, F; Vanoli, J; Mancia, G; Grassi, G
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population
2025 Quarti-Trevano, F; Facchetti, R; Cuspidi, C; Mancia, G; Grassi, G
Reproducibility and Treatment Effect on Office and Ambulatory Pressure Relation
2025 Mancia, G; Facchetti, R; Quarti-Trevano, F; Grassi, G
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)
2025 Ostrowska, A; Wojciechowska, W; Rajzer, M; Weber, T; Bursztyn, M; Persu, A; Stergiou, G; Kiełbasa, G; Chrostowska, M; Doumas, M; Parati, G; Bilo, G; Grassi, G; Mancia, G; Januszewicz, A; Kreutz, R; Narkiewicz, K; Dubiela, A; Imprialos, K; Stavropoulos, K; de Freminville, J; Azizi, M; Cunha, P; Lewandowski, J; Strzelczyk, J; Wuerzner, G; Gosk-Przybyłek, M; Szwęch, E; Prejbisz, A; Van der Niepen, P; Kahan, T; Jekell, A; Spaak, J; Tsioufis, K; Ehret, G; Doroszko, A; Kubalski, P; Polonia, J; Styczkiewicz, K; Styczkiewicz, M; Mazur, S; Veglio, F; Rabbia, F; Eula, E; Águila, F; Sarzani, R; Spannella, F; Jarai, Z; Papadopoulos, D; Sublet, M; Grassos, C; Kahrimanidis, I; Gkaliagkousi, E; Triantafyllou, A; Grodzicki, T; Wizner, B; Seweryn, A; Moczulska, B; Ntineri, A; Robles, N; Widmiski, J; Zbroch, E
Reply to comment on “Cardio-Ankle Vascular Index and left ventricular mass as markers of nocturnal blood pressure fall in the general population”
2024 Cuspidi, C; Facchetti, R; Gherbesi, E; Quarti-Trevano, F; Dell'Oro, R; Mancia, G; Grassi, G
Ambulatory Blood Pressure Phenotypes, Arterial Stiffness, and Cardiac Remodeling
2024 Cuspidi, C; Facchetti, R; Gherbesi, E; Quarti-Trevano, F; Vanoli, J; Mancia, G; Grassi, G
The 2023 European Society of Hypertension guidelines for high blood pressure – What's new on diagnostic and therapeutic approaches
2024 Grassi, G; Kreutz, R; Mancia, G
Randomized Clinical Outcome Trials in Hypertension
2024 Mancia, G; Kjeldsen, S
Changes in blood pressure after catheter-based renal denervation in South Africa
2024 Ebrahim, I; Ntsekhe, M; Rayner, B; Fahy, M; Mancia, G; Böhm, M
The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study)
2024 Wojciechowska, W; Rajzer, M; Kreutz, R; Weber, T; Bursztyn, M; Persu, A; Stergiou, G; Parati, G; Bilo, G; Pac, A; Grassi, G; Mancia, G; Januszewicz, A; Chrostowska, M; Narkiewicz, K; Dubiela, A; Doumas, M; Imprialos, K; Stavropoulos, K; de Freminville, J; Azizi, M; Cunha, P; Lewandowski, J; Strzelczyk, J; Wuerzner, G; Gosk-Przybylek, M; Szwench-Pietrasz, E; Prejbisz, A; Van der Niepen, P; Kahan, T; Jekell, A; Spaak, J; Tsioufis, K; Ehret, G; Doroszko, A; Kubalski, P; Polonia, J; Styczkiewicz, K; Styczkiewicz, M; Mazur, S; Veglio, F; Rabbia, F; Eula, E; Aguila, F; Sarzani, R; Spannella, F; Jarai, Z; Papadopoulos, D; Lopez-Sublet, M; Ostrowska, A; Grassos, C; Kahrimanidis, I; Gkaliagkousi, E; Triantafyllou, A; Grodzicki, T; Wizner, B; Seweryn, A; Moczulska, B; Ntineri, A; Robles, N; Widmiski, J; Zbroch, E
Risk prediction by ambulatory blood pressure monitoring in non-diabetic and diabetic patients: better than office measurements
2024 Mancia, G; Facchetti, R; Grassi, G
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines
2024 Mancia, G; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Muiesan, M; Tsioufis, K; Kjeldsen, S; Kreutz, R
Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study
2024 Morabito, G; Gregorio, C; Ieva, F; Barbati, G; Mancia, G; Corrao, G; Rea, F
Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern
2024 Kreutz, R; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Kjeldsen, S; Muiesan, M; Thomopoulos, C; Tsioufis, K; Mancia, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile